These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2055342)

  • 21. Atrial natriuretic factor in various stages of diabetic nephropathy.
    Sawicki PT; Heinemann L; Rave K; Hohmann A; Berger M
    J Diabet Complications; 1988; 2(4):207-9. PubMed ID: 2976764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
    Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate and blood pressure variations are unaffected in early microalbuminuric type I diabetic subjects.
    Hermans MP; Selvais PL; Ketelslegers JM
    Diabetes Care; 1994 Jun; 17(6):626. PubMed ID: 8082541
    [No Abstract]   [Full Text] [Related]  

  • 24. Is diabetic nephropathy a restorative disease?
    Futrakul N; Futrakul P
    Ren Fail; 2012; 34(5):667-8. PubMed ID: 22563922
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic and hemodynamics aspects of diabetic nephropathy].
    Shestakova MV; Dedov II; Mukhin NA; Sheremet'eva OV
    Probl Endokrinol (Mosk); 1993; 39(3):55-7. PubMed ID: 8058686
    [No Abstract]   [Full Text] [Related]  

  • 26. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
    Mathiesen ER; Feldt-Rasmussen B; Hommel E; Deckert T; Parving HH
    Diabetes Care; 1997 Mar; 20(3):286-9. PubMed ID: 9051373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
    Parving HH
    Diabetologia; 1996 Mar; 39(3):367-8. PubMed ID: 8721786
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diabetic nephropathy in children and adolescents].
    Dumas R
    Arch Pediatr; 1994 May; 1(5):455-7. PubMed ID: 7951828
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetic nephropathy--what does it cause to develop?
    de Jong PE
    Neth J Med; 1988 Oct; 33(3-4):101-5. PubMed ID: 3067096
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J; Bastos M; Melo M; Carvalheiro M
    Acta Med Port; 2007; 20(2):145-50. PubMed ID: 17868520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor I and altered renal hemodynamics in growth hormone deficiency, acromegaly, and type I diabetes mellitus.
    Hoogenberg K; ter Wee PM; Lieverse AG; Sluiter WJ; Dullaart RP
    Transplant Proc; 1994 Apr; 26(2):505-7. PubMed ID: 8171527
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholesterol: a renal risk factor in diabetic nephropathy?
    Mulec H; Johnsen SA; Wiklund O; Björck S
    Am J Kidney Dis; 1993 Jul; 22(1):196-201. PubMed ID: 8322783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ; Sochett EB; Dekker MG; Perkins BA
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in diabetic nephropathy: how big a culprit is glucose?
    Striker GE; Striker LJ
    Diabetes Metab; 1996 Dec; 22(6):407-14. PubMed ID: 8985648
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetic nephropathy.
    Hostetter TH
    N Engl J Med; 1985 Mar; 312(10):642-4. PubMed ID: 3974632
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of short-term inhibition of prostaglandin synthesis on glomerular filtration rate and microalbuminuria in patients with incipient diabetic nephropathy.
    van den Berg BW; Kruseman AC; van Geel JL; Cornelissen P; Mulder AW
    Neth J Med; 1988 Oct; 33(3-4):106-12. PubMed ID: 3226444
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular epithelial foot processes and filtration slits in IDDM patients.
    Bjørn SF; Bangstad HJ; Hanssen KF; Nyberg G; Walker JD; Viberti GC; Osterby R
    Diabetologia; 1995 Oct; 38(10):1197-204. PubMed ID: 8690172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up of glomerular hyperfiltration in normoalbuminuric type 1 (insulin-dependent) diabetic patients.
    Azevedo MJ; Gross JL
    Diabetologia; 1991 Aug; 34(8):611. PubMed ID: 1936666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.